Denali Therapeutics Stock Analysis

Denali Stock Analysis Notes

About 91.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.7. Some equities with similar Price to Book (P/B) outperform the market in the long run. Denali Therapeutics recorded a loss per share of 2.57. The entity had not issued any dividends in recent years. Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California. Denali Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people. To learn more about Denali Therapeutics call Ryan Watts at 650 866 8548 or check out https://www.denalitherapeutics.com.

Denali Therapeutics Investment Alerts

Denali Therapeutics Upcoming and Recent Events

Denali Largest EPS Surprises

View All Earnings Estimates

Denali Therapeutics Environmental, Social, and Governance (ESG) Scores

Denali Therapeutics Thematic Classifications

Denali Stock Institutional Investors

Note, although Denali Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Denali Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.14 B.

Denali Profitablity

Management Efficiency

Denali Therapeutics has return on total asset (ROA) of (0.2482) % which means that it has lost $0.2482 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.374) %, meaning that it created substantial loss on money invested by shareholders. Denali Therapeutics' management efficiency ratios could be used to measure how well Denali Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.32. The current Return On Capital Employed is estimated to decrease to -0.4. As of now, Denali Therapeutics' Asset Turnover is increasing as compared to previous years.

Technical Drivers

As of the 24th of March, Denali Therapeutics shows the Standard Deviation of 4.45, mean deviation of 3.31, and Variance of 19.77. Denali Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Denali Therapeutics Price Movement Analysis

Denali Therapeutics Insider Trading Activities

Denali Therapeutics Outstanding Bonds

Denali Therapeutics Predictive Daily Indicators

Denali Therapeutics Corporate Filings

Denali Therapeutics Forecast Models

Denali Therapeutics' time-series forecasting models are one of many Denali Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Denali Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Denali Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Denali shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Denali Therapeutics. By using and applying Denali Stock analysis, traders can create a robust methodology for identifying Denali entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Denali analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Denali analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Denali Therapeutics stock analysis indicators help investors evaluate how Denali Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Denali Therapeutics shares will generate the highest return on investment. By understating and applying Denali Therapeutics stock analysis, traders can identify Denali Therapeutics position entry and exit signals to maximize returns.

When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.